BioSpace News Archive

Novocure (NASDAQ: NVCR) announced today that William Doyle, the company’s Executive Chairman, and Dr. Uri Weinberg, the company’s Chief Science Officer, will participate in the 2020 Wells Fargo Virtual Healthcare Conference on September 9, 2020. Mr. Doyle and Dr. Weinberg will take part in a fireside chat at 8:40 a.m. EDT. Mr. Doyle and Dr. Weinberg will also participate in one-on-one meetings with investors throughou

Global Blood Therapeutics, Inc. announced that on September 1, 2020, the compensation committee of GBT’s board of directors granted seven new employees options to purchase an aggregate of 11,678 shares of the company’s common stock with a per share exercise price of $60.45 and restricted stock units for an aggregate of 46,585 shares of the company’s common stock.

Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming Morgan Stanley 2020 Healthcare Conference. Silk Road Medical’s management is scheduled to present on Friday, September 18 at 11:45 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of t

MEI Pharma, Inc. (NASDAQ: MEIP) (“MEI”), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced its participation in the following upcoming virtual investor conferences: Wells Fargo 2020 Virtual Healthcare Conference on Thursday, September 10, 2020 at 2:40 p.m. ET H.C. Wainwright

Cygnal Therapeutics, the first company to build a platform to develop drugs in the new field of exoneural biology , today announced that Pearl Huang, Ph.D., President and Chief Executive Officer, will present a company overview as part of Wells Fargo’s 2020 Virtual Healthcare Conference on Wednesday, September 9, 2020 at 3:

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the BofA Global Healthcare Conference 2020 on Wednesday, September 16, 2020 at 10:05 a.m. ET. Prahlad Singh, president and chief executive officer of PerkinElmer, will provide an overview of the Company and it

UroGen Pharma Ltd. a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options, announced the grants of inducement restricted stock units to nineteen new employees in connection with their employment with UroGen.

Brings over 20 years of commercial and medical expertise in the pharmaceutical industry and the cannabis space

Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present the latest company overview at the 18 th Annual Morgan Stanley Global Healthcare Conference. The conference is being conducted in a virtual format and the presentation will take place on Thursday, September 17, 2020 at 2:45 p.m. Eastern Time. A live web

– Prescription Drug User Fee Act (PDUFA) target action date of June 25, 2021 – – FDA indicated that it is currently not planning to hold an Advisory Committee Meeting –